Articles tagged with Multiple Sclerosis
Researchers have created the largest collection of patient stem cell models of multiple sclerosis, identifying unique ways in which glia contribute to the disease. The study suggests that glial cells from MS patients have intrinsic hallmarks of disease, independent of immune system influences.
A new study from Washington University School of Medicine found that people with multiple sclerosis are less likely to develop the molecular hallmarks of Alzheimer's disease. The discovery suggests a potential new avenue for treating Alzheimer's and could inform therapeutic strategies.
A new study published in Neurology found that COVID-19 vaccination does not increase the risk of relapse in people with multiple sclerosis. However, participants with high MS activity and those who received booster doses did show a small increased risk, especially if they were not taking disease-modifying treatments.
A Wayne State University research team led by Taylor Takla is studying the neural, motor, cognitive and psychological factors underlying fear of falling in multiple sclerosis patients. The goal is to break the cycle of falls, reduced physical activity and social isolation, ultimately improving quality of life for MS patients.
Fatigue affects up to 90% of individuals with MS, significantly impacting their daily lives. The study proposes that disruptions in the cortico-striato-thalamo-cortical loop contribute to central fatigue.
Researchers have developed a new therapy called PIPE-307 that targets an elusive receptor on certain cells in the brain, prompting them to mature into myelin-producing oligodendrocytes. This could potentially reverse damage caused by multiple sclerosis, leading to improved movement, balance, and vision.
A new study published in PLOS Digital Health found that machine learning models can reliably predict the disability progression of multiple sclerosis. The models were trained on data from 15,240 adults with at least three years of MS history and had an average accuracy of 0.71 ± 0.01.
A recent study published in Scientific Reports found that blocking connexin 43 (Cx43) channels with the compound INI-0602 improved MS symptoms in an animal model by regulating immune processes and reducing inflammation. The findings suggest a potential therapeutic strategy for chronic MS treatment.
Researchers study T cells and monocytes interaction in the meninges before they attack the brain and spinal cord, potentially leading to new disease progression targets. The findings could provide a pathway to treating other neurological diseases like Alzheimer's and Parkinson's.
Researchers at Durham University have developed a groundbreaking method to diagnose Multiple Sclerosis using advanced eye imaging techniques. The innovative approach integrates optical coherence tomography and infrared scanning laser ophthalmoscopy, achieving an impressive 92% accuracy in initial tests.
A new study published in Neurology found that ofatumumab is more effective than teriflunomide at helping people with relapsing-remitting MS reach a period of no disease activity across racial and ethnic groups. The medication showed consistent results among diverse populations, including Black, Hispanic, and Asian individuals.
The WISDOM project aims to integrate healthcare and research data to combat CIMDs through AI-driven models. The initiative hopes to improve disease diagnosis, treatment, and patient outcomes by sharing data securely across borders.
Researchers have discovered several rare types of helper T cells associated with immune disorders such as multiple sclerosis and rheumatoid arthritis. The study found that genetic variants in bidirectional enhancer DNA are linked to specific immune-mediated diseases, including inflammatory bowel disease.
A pilot study found that remote cognitive rehabilitation using TELE-Self-GEN improved memory performance and daily life functionality in individuals with MS. The virtual intervention demonstrated high levels of participant satisfaction and effectiveness.
A pilot study found that methylphenidate enhances oculomotor function in individuals with multiple sclerosis, improving visual processing speed. The treatment also showed promise for mitigating cognitive symptoms associated with MS.
A new methodology, backward walking speed reserve, measures an individual's capacity to increase their walking speed on demand in the backward direction. This assessment is linked to disease severity, falls risk, and cognitive decline in multiple sclerosis patients.
Researchers at University of Cambridge uncover unified healer army of regulatory T cells that constantly move and repair damaged tissue. This discovery has implications for treating various diseases, including autoimmune disorders and infectious diseases.
Researchers investigate Epstein-Barr Virus and Multiple Sclerosis connection, discovering cross-reactivity between viral proteins and brain proteins. The study suggests that differences in immune cell function may explain why some people develop MS after EBV infection.
Researchers discovered how Epstein-Barr virus (EBV)-infected B cells contribute to multiple sclerosis (MS) inflammation and disease. A new treatment strategy targeting these problematic cells may offer a selectively cytotoxic approach to MS therapy.
Researchers found that abnormally active B cell metabolism causes an inflammatory immune response in individuals with Multiple Sclerosis (MS), leading to nerve damage and symptoms. Emerging BTK inhibitors alter this abnormal B cell respiration, stopping the signaling that leads to MS flare-ups.
FutureNeuro, a leading SFI Research Centre, is expanding its research programme with a focus on diagnostics, therapeutics, and digital health. The centre aims to develop precision diagnostics, future treatments, and systems using real-time health data.
A new study found extensive alternative splicing of messenger RNA in untreated multiple sclerosis patients compared to healthy controls. Interferon-ß therapy corrected dysregulated alternative splicing, linking it to future clinical exacerbations.
Researchers have discovered a small molecule compound called ESI1 that can regenerate vital myelin coatings, potentially treating multiple sclerosis and age-related cognitive deficits. The treatment promotes healing by clearing a roadblock in the repair process, allowing oligodendrocytes to produce myelin sheaths.
Alexander Gow is studying the disease's effects on oligodendrocytes to provide new insight into the development and origins of MS. He aims to develop improved treatments by identifying a protein called Trb3 that may be a good drug target for the disease.
A study published by the American Academy of Neurology found that immigrants to Canada who spend a greater proportion of their lives in the country have a higher risk of developing multiple sclerosis. The study involved 1.5 million immigrants and found that those who spent 70% of their lives in Canada were 38% more likely to develop MS.
Researchers found that older adults tend to conserve energy by modifying their movements under certain circumstances. The findings suggest that the effort costs of reaching are a determining factor in slowing movement with age. This research may lead to new tools for diagnosing diseases, including Parkinson's and multiple sclerosis.
A new study from Brigham and Women's Hospital suggests that PET brain scans can detect hidden inflammation in MS patients who are being treated with highly-effective treatments. The findings indicate that smoldering inflammation may linger in patients, driving disease progression and symptoms.
Researchers have identified CAR-T cell therapy as a potential treatment for autoimmune diseases such as rheumatoid arthritis, SLE, and type 1 Diabetes Mellitus. Early studies have shown promising results in reducing disease activity and improving patients' quality of life, but long-term data on safety and efficacy is limited.
Researchers identified a unique autoantibody signature in approximately 10% of patients with MS, appearing years before symptom onset. This finding could revolutionize patient care and treatment strategies for multiple sclerosis.
Scientists have identified a consistent signature of multiple sclerosis in the blood of patients years before they develop symptoms. The discovery, published in Nature Medicine, could lead to earlier diagnosis and treatment of the disease, affecting nearly 1 million people in the US.
Researchers used fitness trackers and smartphone data from 55 MS patients and 24 controls to identify clinically useful information. Data on physical activity, heart rate variability, and phone usage revealed relationships between disease severity, fatigue levels, and motor function.
A new study by Kessler Foundation scientist Glenn Wylie will independently investigate brain networks associated with 'state' fatigue in MS. The research aims to validate 'state' measures of fatigue and offer a more accurate assessment of primary fatigue, potentially improving the quality of life for individuals living with MS.
A team of researchers at Trinity College Dublin has developed a new blood test that measures the immune response to Epstein Barr Virus (EBV), which is the leading risk factor for multiple sclerosis (MS). The study found that people with MS have a higher immune response to EBNA-1, a part of the EBV, compared to those without MS.
Researchers have identified three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. These findings could lead to more effective and tailored treatment strategies for patients with the disease.
Dr. Rhonda Voskuhl's groundbreaking research has shed light on the mechanisms underlying sex differences in MS, highlighting a gene on female sex chromosomes that promotes inflammation and brain-protective effects of estrogen. Her work may lead to new treatment approaches for MS.
Researchers discovered that mature oligodendrocytes, critical for brain function, can survive for up to 45 days after a fatal trauma, defying the classical programmed cell-death pathway. This finding opens new avenues for understanding and potentially preventing damage caused by aging and neurodegenerative diseases.
A UK study found that individuals with multiple sclerosis had a seven times greater risk of hospitalization and a four-fold increased risk of dying from COVID-19, even after repeated doses of vaccines. Vaccination alone may not adequately protect this vulnerable population, highlighting the need for additional preventive measures.
A study found that children and adolescents with obesity are at a significantly higher risk of developing multiple sclerosis, with the risk being more than two-fold. The study also suggests that the persistent low-grade inflammatory state associated with obesity may be mediating this association.
A team of researchers has developed the world's first 3D-printed brain phantom, which can be imaged using dMRI. The brain model is made up of microchannels that mimic nerve cells in the brain, allowing for more accurate analysis and research into neurodegenerative diseases.
Researchers at Brigham and Women's Hospital discovered that astrocytes, non-immune cells, can develop aspects of immune memory. This epigenetic memory promotes CNS pathology in autoimmune inflammation, including chronic neurologic disorders like multiple sclerosis.
Scientists at Karolinska Institutet and Stockholm University have mapped the cellular architecture of MS lesions using advanced methodology. This reveals how immune cells and glial cells interact in the disease.
Researchers found that ageing reduces the ability of regulatory T cells to enhance myelin regeneration, which can have profound consequences for neurological functions. The study suggests that the loss of function may be reversible, and two new molecules, ITGA2 and MCAM, have been identified as potential therapeutic targets.
A new study found that infants exposed to monoclonal antibodies for multiple sclerosis through breastfeeding experienced no negative effects on health or development within the first three years of life. The research used data from 183 infants born to mothers taking these medications while breastfeeding, and compared them to another gr...
Researchers have developed a genetic risk tool that combines genetic factors with demographic information to improve MS risk prediction in young people presenting with optic neuritis. The study shows that this approach can help identify patients at high risk of MS, potentially enabling earlier treatment and improving long-term health.
Scientists studied clusters of immune cells called microglia in normal-appearing white matter to understand their role in Multiple Sclerosis. They found that these nodules are associated with worsened pathology, more lesions, and inflammation, and may be activated by oxidized lipids.
Researchers have discovered a previously unknown mechanism behind immune tolerance, where B cells teach T cells to ignore the body's own proteins. This failure can lead to autoimmune diseases such as Multiple Sclerosis-like Neuromyelitis optica.
A new computational biology tool has analyzed the complex biological networks of multiple sclerosis patients, revealing relationships between genes, proteins, cells, brain function, and behavior. The study identified correlations between protein MK03 and immune system cell counts, retinal nerve fiber thickness, and gait test results.
Researchers at ETH Zurich have developed a new magnetic resonance imaging (MRI) procedure that maps the condition of myelin sheaths in the central nervous system more accurately. This breakthrough technology has the potential to facilitate early MS diagnosis and monitoring, as well as the development of new drugs for the disease.
A study published in Lancet eClinical Health found pregnancy outcomes for pregnant individuals with autoimmune disease vary greatly depending on the specific condition and individual factors. Research highlights the importance of considering comorbidities when discussing autoimmune disease and pregnancy.
A team of neuroscientists has discovered that oligodendrocytes, myelin-forming cells, accelerate glucose consumption to deliver energy-rich molecules to rapidly firing axons. This communication is mediated by potassium signals and maintains axonal health.
A new study published in Neurology found that young Black and Hispanic women with multiple sclerosis face greater challenges in pregnancy, have more advanced disease, and experience higher inflammation levels, which may signal MS progression. The researchers also noted disparities in healthcare access and treatment.
A new study will compare the effects of a single bout of cycling alone to two different cycling experiences enhanced with VR technology. The goal is to uncover the relationship between sensory demand and acute improvements in processing speed, informing future research on exercise training for long-term benefits.
Researchers discovered that a little-understood synapse in the brain plays a pivotal role in producing myelin, the protective sheath around nerve cells. This finding could lead to new therapies for multiple sclerosis, neurodegenerative conditions and brain cancer.
A Kessler Foundation researcher will examine the impact of social determinants on brain health and MS outcomes in Latinos. The study aims to improve healthcare access and quality for this minoritized group.
A large-scale ancient human gene bank analysis revealed that genetic variants increasing MS risk were introduced by sheep and cattle herders 5,000 years ago. This finding explains the North-South Gradient of MS prevalence in Europe.
A combination of 11 proteins can predict long-term disability outcomes in multiple sclerosis, making it possible to tailor treatments to individual patients. The study identified a specific protein, neurofilament light chain, as a reliable biomarker for disease activity.
Research from Michigan Medicine found that widespread pain with nociplastic features can make physical activity challenging for patients with multiple sclerosis. The study suggests tailoring exercise plans to individual needs by considering underlying pain mechanisms, aiming to maintain functional independence and reduce pain intensity.
Researchers from UTHealth Houston discovered that Epstein-Barr virus (EBV)-specific T-cells are present in high numbers in the cerebrospinal fluid of people with multiple sclerosis at its earliest stages. The study suggests that these cells may be contributing to the disease's pathogenesis.
Women with autoimmune disease are 30% more likely to experience perinatal depression, while those with perinatal depression have a 30% higher risk of developing an autoimmune disease. The strongest association is seen with multiple sclerosis.
Researchers investigated cognitive fatigue across multiple sclerosis, traumatic brain injury, and controls using two tasks, finding that fatigue was consistent across participants regardless of task. Cognitive fatigue correlated with longer response times and activation in the caudate nucleus and thalamus.